Related Experiment Videos

E2F1 pathways to apoptosis

Doron Ginsberg1

  • 1Department of Molecular Cell Biology, The Weizmann Institute of Science, 76100, Rehovot, Israel. doron.ginsberg@weizmann.ac.il

FEBS Letters
|October 2, 2002
PubMed

Insights

The E2F1 transcription factor regulates cell growth and can trigger apoptosis, a programmed cell death. Its deregulation in cancer may act as a safeguard, eliminating pre-malignant cells and preventing tumor development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The E2F family of transcription factors is crucial for controlling cell proliferation.
  • Dysregulation of E2F activity is frequently observed in human cancers.
  • E2F1 has a dual role, capable of promoting both cell proliferation and apoptosis.

Purpose of the Study:

  • To elucidate the role of E2F1 in cell proliferation and apoptosis.
  • To investigate the pathways through which E2F1 induces apoptosis, including its relationship with p53.
  • To understand the implications of E2F1 deregulation in the context of oncogenic stress and tumor suppression.

Main Methods:

  • Analysis of E2F1's function in cell proliferation.
  • Investigation of E2F1-induced apoptotic pathways.
  • Examination of the interaction between E2F1 and the tumor suppressor p53.

Main Results:

  • E2F1 can induce both cell proliferation and apoptosis.
  • E2F1-mediated apoptosis involves pathways that stabilize and activate the tumor suppressor p53.
  • The pro-apoptotic function of E2F1 was demonstrated.

Conclusions:

  • E2F1's pro-apoptotic activity suggests a tumor-suppressive role.
  • Deregulation of E2F1 may act as oncogenic stress, initiating apoptosis in pre-malignant cells.
  • This mechanism could prevent tumor development by eliminating cells with oncogenic potential.

Related Concept Videos